Search Results - "Proot, Pieter"

Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study by Vencio, Sérgio, Manosalva, Juan P, Mathieu, Chantal, Proot, Pieter, Lozno, Hernan Yupanqui, Paldánius, Päivi M

“…Abstract Background Patients with type 2 diabetes mellitus (T2DM) from Latin American countries face challenges in access to healthcare, leading to…”
Get full text

Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus by Yoo, Soon-Jib, Chang, Sang-Ah, Sohn, Tae Seo, Kwon, Hyuk-Sang, Lee, Jong Min, Moon, Sungdae, Proot, Pieter, Paldánius, Päivi M, Yoon, Kun Ho

“…We assessed the glycaemic durability with early combination (EC; vildagliptin+metformin [MET], n=22) versus MET monotherapy (n=17), among newly-diagnosed type…”
Get full text

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial by Matthews, David R, Paldánius, Päivi M, Proot, Pieter, Chiang, YannTong, Stumvoll, Michael, Del Prato, Stefano

“…Early treatment intensification leading to sustained good glycaemic control is essential to delay diabetic complications. Although initial combination therapy…”
Get full text

Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity by Bays, Harold E., Kozlovski, Plamen, Shao, Qing, Proot, Pieter, Keefe, Deborah

“…Objective The aim of this study was to explore the dose response of licogliflozin, a dual inhibitor of sodium/glucose cotransporter 1 (SGLT1) and 2 (SGLT2), by…”
Get full text

Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin vs placebo or empagliflozin in patients with type 2 diabetes and heart failure by Boer, Rudolf A., Núñez, Julio, Kozlovski, Plamen, Wang, Yi, Proot, Pieter, Keefe, Deborah

“…Aims Explore the efficacy, safety and tolerability of the dual sodium–glucose cotransporter (SGLT) 1 and 2 inhibitor, licogliflozin in patients with type‐2…”
Get full text

94-LB: Long-Term Clinical Benefits of Early Combination Approach in Latin American Subpopulation of VERIFY Study by VENCIO, SERGIO, MANOSALVA, JUAN, MATHIEU, CHANTAL, PROOT, PIETER, PALDANIUS, PAIVI M.

“…The VERIFY study showed long-term clinical benefits of the early combination therapy of vildagliptin with metformin (EC) vs. traditional stepwise approach…”
Get full text

A pre‐specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM by Matthews, David R., Paldánius, Päivi M., Stumvoll, Michael, Han, Jackie, Bader, Giovanni, Chiang, YannTong, Proot, Pieter, Del Prato, Stefano

“…Aims To ensure the integrity of the planned analyses and maximize the clinical utility of the VERIFY study results by describing the detailed concepts behind…”
Get full text

FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study by Hoitsma, Andries J., Woodle, Ervin S., Abramowicz, Daniel, Proot, Pieter, Vanrenterghem, Yves

“…Background. FTY720 (fingolimod), a novel immunomodulator, has demonstrated potential for prevention of acute rejection in combination with cyclosporine…”
Get full text

Pharmacokinetics of Sotrastaurin Combined With Tacrolimus or Mycophenolic Acid in De Novo Kidney Transplant Recipients by KOVARIK, John M, STEIGER, Jürg U, GRINYO, Josep M, ROSTAING, Lionel, ARNS, Wolfgang, DANTAL, Jacques, PROOT, Pieter, BUDDE, Klemens

“…Sotrastaurin is a protein kinase C inhibitor in the development for prevention of organ rejection after renal transplantation. In a multicenter phase 2 trial,…”
Get full text

Differential cytotoxic effects induced after photosensitization by hypericin by Vandenbogaerde, Ann L., Cuveele, Joel F., Proot, Pieter, Himpens, Bernard E., Merlevede, Wilfried J., de Witte, Peter A.

“…The cytotoxic effects of the natural photosensitizing agent hypericin were evaluated. A dramatic difference in the sensitivity of several different human and…”
Get full text

Stability of adenosine in infusion by Proot, Pieter, Van Schepdael, Ann, Raymakers, Albert A, Hoogmartens, Jos

“…Using liquid chromatography the stability of adenosine in aqueous solution was investigated at five different temperatures, namely 4, 22, 37, 60 and 72°C over…”
Get full text